Brightsurf Science News & Current Events

September 29, 2002
TRUST 2002 study shows levofloxacin resistance remains rare in S. pneumoniae
TRUST 6, the largest, longest-running and broadest surveillance of resistance patterns, shows that resistance to levofloxacin is relatively rare in the treatment of S. pneumoniae and remains low (0.9%) compared to other antibiotic classes.

Findings aid understanding of neurodegenerative diseases
Northwestern University scientists have made a key molecular discovery that has implications for a wide range of diseases characterized by the loss of nerve function, including Huntington's, Parkinson's, Alzheimer's and Lou Gehrig's diseases, cystic fibrosis and Creutzfeldt-Jakob disease, the human form of mad cow disease.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.